PMID- 31709540 OWN - NLM STAT- MEDLINE DCOM- 20210309 LR - 20210309 IS - 1097-4652 (Electronic) IS - 0021-9541 (Linking) VI - 235 IP - 6 DP - 2020 Jun TI - Leukemia stem cell immunophenotyping tool for diagnostic, prognosis, and therapeutics. PG - 4989-4998 LID - 10.1002/jcp.29394 [doi] AB - The existence of cancer stem cells is debatable in numerous solid tumors, yet in leukemia, there is compelling evidence of this cell population. Leukemic stem cells (LSCs) are altered cells in which accumulating genetic and/or epigenetic alterations occur, resulting in the transition between the normal, preleukemic, and leukemic status. These cells do not follow the normal differentiation program; they are arrested in a primitive state but with high proliferation potential, generating undifferentiated blast accumulation and a lack of a mature cell population. The identification of LSCs might guide stem cell biology research and provide key points of distinction between these cells and their normal counterparts. The identification and characterization of the main features of LSCs can be useful as tools for diagnosis and treatment. In this context, the aim of the present review was to connect immunophenotype data in the main types of leukemia to further guide technical improvements. CI - (c) 2019 Wiley Periodicals, Inc. FAU - Mastelaro de Rezende, Marina AU - Mastelaro de Rezende M AUID- ORCID: 0000-0002-8934-2108 AD - Departamento de Bioquimica, Universidade Federal de Sao Paulo (UNIFESP), Sao Paulo, Brazil. FAU - Ferreira, Alice T AU - Ferreira AT AD - Departamento de Biofisica, Universidade Federal de Sao Paulo (UNIFESP), Sao Paulo, Brazil. FAU - Paredes-Gamero, Edgar J AU - Paredes-Gamero EJ AD - Departamento de Bioquimica, Universidade Federal de Sao Paulo (UNIFESP), Sao Paulo, Brazil. AD - Division - Faculdade de Ciencias Farmaceuticas, Alimentos e Nutricao, Universidade Federal do Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20191110 PL - United States TA - J Cell Physiol JT - Journal of cellular physiology JID - 0050222 RN - 0 (Biomarkers, Tumor) SB - IM MH - Biomarkers, Tumor/immunology/therapeutic use MH - Cell Differentiation/immunology MH - Flow Cytometry MH - Humans MH - Immunophenotyping/*trends MH - Leukemia/*diagnosis/*immunology/pathology/therapy MH - Neoplastic Stem Cells/*immunology/pathology MH - Prognosis OTO - NOTNLM OT - cytometry OT - immunophenotype OT - leukemia OT - leukemic stem cell OT - surface markers EDAT- 2019/11/12 06:00 MHDA- 2021/03/10 06:00 CRDT- 2019/11/12 06:00 PHST- 2019/07/07 00:00 [received] PHST- 2019/10/25 00:00 [accepted] PHST- 2019/11/12 06:00 [pubmed] PHST- 2021/03/10 06:00 [medline] PHST- 2019/11/12 06:00 [entrez] AID - 10.1002/jcp.29394 [doi] PST - ppublish SO - J Cell Physiol. 2020 Jun;235(6):4989-4998. doi: 10.1002/jcp.29394. Epub 2019 Nov 10.